Anime for gamers hits differently because it understands the grind. It captures that feeling of spending 60 hours chasing ...

Even your Legos are going through a technological revolution. The toy company unveiled its “most significant evolution” in 50 years — the Lego Smart Brick, a standard 2×4 Lego brick with a tiny ...

Why did humans evolve the eyes we have today? While scientists can't go back in time to study the environmental pressures that shaped the evolution of the diverse vision systems that exist in nature, ...

As AI systems have advanced rapidly, with large language models (LLMs) at the center, every tech executive has experienced their limits—when AI systems struggle with complex problem-solving, produce ...

Please provide your email address to receive an email when new articles are posted on . Approximately 54% of individuals in the U.S. are affected by a neurological disorder, with headache the most ...

As AI becomes embedded in more aspects of healthcare, health systems are at a crossroads: Should they rely on ambient documentation tools bundled with their EHRs or invest in more powerful third-party ...

Americans increasingly turn to seafood for health benefits, yet many remain unaware of which varieties offer maximum nutritional value while minimizing potential risks. The distinction matters: ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...

Michael Ingram is a Senior Contributor from the United States of America. Michael has been writing for GameRant since 2021, writing both analytically and fiction for years beforehand. Michael is a ...

Explore the fascinating journey of strata-cut and stop motion animation from its initial concept to the final masterpiece. Learn about the unique techniques, creative challenges, and innovations that ...

ClearPoint Neuro Inc. (NASDAQ:CLPT) shares are trading higher Wednesday after the company announced results from a Phase I-II clinical study evaluating its ClearPoint Prism Neuro Laser Therapy System.